Clinical Trial Update: Hydrocortisone for BPD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating hydrocortisone for bronchopulmonary dysplasia in preterm infants has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Infant, Newborn, Infant, Small for Gestational Age | Phase 3 | Status: COMPLETED | Results posted: 2022-08-19